Cargando…
Efficacy and safety of decitabine combined with low-dose cytarabine, aclarubicin, and granulocyte colony-stimulating factor compared with standard therapy in acute myeloid leukemia patients with TP53 mutation
| Autores principales: | , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Lippincott Williams & Wilkins
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8213253/ https://www.ncbi.nlm.nih.gov/pubmed/33323826 http://dx.doi.org/10.1097/CM9.0000000000001316 |
| _version_ | 1783709805556269056 |
|---|---|
| author | Chen, Si-Si Sun, Qian Cao, Lan Wu, Wen-Zhong Xie, Yue Qiao, Chun Li, Jian-Yong Qian, Si-Xuan Hong, Ming |
| author_facet | Chen, Si-Si Sun, Qian Cao, Lan Wu, Wen-Zhong Xie, Yue Qiao, Chun Li, Jian-Yong Qian, Si-Xuan Hong, Ming |
| author_sort | Chen, Si-Si |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8213253 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | Lippincott Williams & Wilkins |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-82132532021-06-22 Efficacy and safety of decitabine combined with low-dose cytarabine, aclarubicin, and granulocyte colony-stimulating factor compared with standard therapy in acute myeloid leukemia patients with TP53 mutation Chen, Si-Si Sun, Qian Cao, Lan Wu, Wen-Zhong Xie, Yue Qiao, Chun Li, Jian-Yong Qian, Si-Xuan Hong, Ming Chin Med J (Engl) Clinical Observations Lippincott Williams & Wilkins 2021-06-20 2020-12-08 /pmc/articles/PMC8213253/ /pubmed/33323826 http://dx.doi.org/10.1097/CM9.0000000000001316 Text en Copyright © 2021 The Chinese Medical Association, produced by Wolters Kluwer, Inc. under the CC-BY-NC-ND license. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (CCBY-NC-ND), where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal. http://creativecommons.org/licenses/by-nc-nd/4.0 (https://creativecommons.org/licenses/by-nc-nd/4.0/) |
| spellingShingle | Clinical Observations Chen, Si-Si Sun, Qian Cao, Lan Wu, Wen-Zhong Xie, Yue Qiao, Chun Li, Jian-Yong Qian, Si-Xuan Hong, Ming Efficacy and safety of decitabine combined with low-dose cytarabine, aclarubicin, and granulocyte colony-stimulating factor compared with standard therapy in acute myeloid leukemia patients with TP53 mutation |
| title | Efficacy and safety of decitabine combined with low-dose cytarabine, aclarubicin, and granulocyte colony-stimulating factor compared with standard therapy in acute myeloid leukemia patients with TP53 mutation |
| title_full | Efficacy and safety of decitabine combined with low-dose cytarabine, aclarubicin, and granulocyte colony-stimulating factor compared with standard therapy in acute myeloid leukemia patients with TP53 mutation |
| title_fullStr | Efficacy and safety of decitabine combined with low-dose cytarabine, aclarubicin, and granulocyte colony-stimulating factor compared with standard therapy in acute myeloid leukemia patients with TP53 mutation |
| title_full_unstemmed | Efficacy and safety of decitabine combined with low-dose cytarabine, aclarubicin, and granulocyte colony-stimulating factor compared with standard therapy in acute myeloid leukemia patients with TP53 mutation |
| title_short | Efficacy and safety of decitabine combined with low-dose cytarabine, aclarubicin, and granulocyte colony-stimulating factor compared with standard therapy in acute myeloid leukemia patients with TP53 mutation |
| title_sort | efficacy and safety of decitabine combined with low-dose cytarabine, aclarubicin, and granulocyte colony-stimulating factor compared with standard therapy in acute myeloid leukemia patients with tp53 mutation |
| topic | Clinical Observations |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8213253/ https://www.ncbi.nlm.nih.gov/pubmed/33323826 http://dx.doi.org/10.1097/CM9.0000000000001316 |
| work_keys_str_mv | AT chensisi efficacyandsafetyofdecitabinecombinedwithlowdosecytarabineaclarubicinandgranulocytecolonystimulatingfactorcomparedwithstandardtherapyinacutemyeloidleukemiapatientswithtp53mutation AT sunqian efficacyandsafetyofdecitabinecombinedwithlowdosecytarabineaclarubicinandgranulocytecolonystimulatingfactorcomparedwithstandardtherapyinacutemyeloidleukemiapatientswithtp53mutation AT caolan efficacyandsafetyofdecitabinecombinedwithlowdosecytarabineaclarubicinandgranulocytecolonystimulatingfactorcomparedwithstandardtherapyinacutemyeloidleukemiapatientswithtp53mutation AT wuwenzhong efficacyandsafetyofdecitabinecombinedwithlowdosecytarabineaclarubicinandgranulocytecolonystimulatingfactorcomparedwithstandardtherapyinacutemyeloidleukemiapatientswithtp53mutation AT xieyue efficacyandsafetyofdecitabinecombinedwithlowdosecytarabineaclarubicinandgranulocytecolonystimulatingfactorcomparedwithstandardtherapyinacutemyeloidleukemiapatientswithtp53mutation AT qiaochun efficacyandsafetyofdecitabinecombinedwithlowdosecytarabineaclarubicinandgranulocytecolonystimulatingfactorcomparedwithstandardtherapyinacutemyeloidleukemiapatientswithtp53mutation AT lijianyong efficacyandsafetyofdecitabinecombinedwithlowdosecytarabineaclarubicinandgranulocytecolonystimulatingfactorcomparedwithstandardtherapyinacutemyeloidleukemiapatientswithtp53mutation AT qiansixuan efficacyandsafetyofdecitabinecombinedwithlowdosecytarabineaclarubicinandgranulocytecolonystimulatingfactorcomparedwithstandardtherapyinacutemyeloidleukemiapatientswithtp53mutation AT hongming efficacyandsafetyofdecitabinecombinedwithlowdosecytarabineaclarubicinandgranulocytecolonystimulatingfactorcomparedwithstandardtherapyinacutemyeloidleukemiapatientswithtp53mutation |